Clinical trial
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)
NCT00287508 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00287508 |
|---|---|
| Title | Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) |
| Official title | Emboshield and Xact Post Approval Carotid Stent Trial Using the Emboshield® BareWire™ Rapid Exchange Embolic Protection System and Xact® Rapid Exchange Carotid Stent System |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Carotid Artery Disease, Carotid Stenosis, Stroke, Atherosclerosis |
| Intervention type | Device |
| Interventions | Carotid artery stenting with filter (interventional) |
| Enrollment | 1,500 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Feb 7, 2006 |
| Last update posted | Oct 17, 2008 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: